一项超声半定量评分的观测研究,用于预测痛风发作风险
1Department of Rheumatology, Chongqing City Hospital of Traditional Chinese Medicine, No. 6, Pan Xi Qi Zhi Road, 400021, Jiang Bei District Chongqing, China.
Zeitschrift fur Rheumatologie
|November 25, 2024
概括
超声半定量评分有效地预测了超过12个月的痛风爆发. 关键指标包括DC信号,tophi和PD活动,有助于对痛风患者的风险评估.
科学领域:
- 类风湿病学 类风湿病学
- 医疗成像医学成像
- 痛风病理生理学
背景情况:
- 痛风是一种常见的炎症性关节炎,其特点是反复爆发.
- 预测痛风爆发对于有效的患者管理和治疗至关重要.
- 目前用于爆发预测的方法可能缺乏精度.
研究的目的:
- 为了确定痛风的半定量超声波评分是否能在12个月内预测发作.
- 为了识别特定的超声波特征,可以独立预测痛风爆发.
主要方法:
- 一项为期12个月的前性观察性研究招募了痛风患者.
- 基线超声波评估评估了14个关节和10个肌的特定特征.
- 进行了半定量评分,用于DC标志,聚合物,托菲,骨质侵蚀,突性缩,PD活性和紧突炎.
主要成果:
- 119名参与者完成了这项研究,61%的人至少经历过一次爆发.
- 基线超声波发现DC信号,聚合物,托菲,骨质侵蚀和PD活动与爆发相关.
- 电直线信号,托菲和PD活动得分是爆发的独立预测指标 (p < 0.05).
结论:
- 半定量超声波评分可以预测痛风爆发的风险.
- 关于DC信号,托菲和PD活动的超声波发现是未来痛风爆发的重要独立预测因素.
相关概念视频
Ultrasonography
4.3K
Ultrasonography is an imaging technique that uses high-frequency sound waves to visualize the body's internal structures. It is a non-invasive and safe procedure that does not involve the use of ionizing radiation, making it widely used in various medical fields. Ultrasonography is used to study heart function, blood flow in the neck or extremities, certain conditions such as gallbladder disease, and fetal growth and development.
During an ultrasonography procedure, a handheld device called...
During an ultrasonography procedure, a handheld device called...
4.3K
Ultrasound II: Endoscopic Ultrasound and FibroScan
78
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
78
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3


